For citations:
Rozhinskaya L.Ya., Gronskaia S.A., Mamedova E.O., Belaya Zh.E., Melnichenko G.A. The comparative efficiency of denosumab treatment in patients with postmenopausal osteoporosis, primary hyperparathyroidism and glucocorticoid-induced osteoporosis in real clinical practice. Osteoporosis and Bone Diseases. 2020;23(1):4-13. (In Russ.) https://doi.org/10.14341/osteo12415
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
